An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data

CompletedOBSERVATIONAL
Enrollment

5,484

Participants

Timeline

Start Date

January 12, 2020

Primary Completion Date

December 20, 2020

Study Completion Date

January 20, 2021

Conditions
Reproductive IssuesReproductive DisorderFertility DisordersFertility IssuesGynecologic DiseaseIVF
Interventions
DRUG

Follitropin Alfa

Subcutaneous injection of follitropin alpha biosimilar only, with daily dose 100-300 IU for 10 days, maximum of 15 days, using antagonists of GnRH or agonist of GnRH.

DRUG

Follicle Stimulating Hormone/Luteinizing Hormone

Subcutaneous injection of follitropin alpha biosimilar, with daily dose 100-300 IU for at least 5 days, than added another gonadotropin for a maximum of 10 days, using antagonists of GnRH or agonist of GnRH.

DRUG

Follitropin Alfa

Subcutaneous injection of follitropin alpha biosimilar only, with daily dose 100-300 IU for 10 days, maximum of 15 days, using antagonists of GnRH only for suppression.

DRUG

Follitropin Alfa

Subcutaneous injection of follitropin alpha biosimilar only, with daily dose 100-300 IU for 10 days, maximum of 15 days, using agonists of GnRH only for suppression.

DRUG

Follicle Stimulating Hormone/Luteinizing Hormone

Overall ovarian stimulation protocols with follitropin alpha biosimilar for at least 5 days+other recombinant and menotropins and short (antagonists of GnRH) or long protocol (agonist of GnRH).

Trial Locations (35)

Unknown

Center for reproductive medicine, Barnaul, Barnaul

Center for reproductive medicine, Irkutsk, Irkutsk

"Clinic Mother and Child Kazan", Kazan'

"Clinic Mother and Child Kostroma", Kostroma

"Clinic Mother and Child Krasnodar", Krasnodar

Center for reproductive medicine, Krasnoyarsk, Krasnoyarsk

AltraVita IVF clinic, Moscow

"Center of Reproductive Medicine and Genetics Nova Clinic", Moscow

"Clinic Mather and Child Lefortovo", Moscow

"Clinic Mather and Child Savelovskaya", Moscow

"Clinic Mother and Child Khodynskoe Pole", Moscow

"Clinic Mother and Child Kuntsevo", Moscow

"Clinic Mother and Child South-West", Moscow

Clinical Hospital MD GROUP (Perinatal Center on Sevastopolskiy), Moscow

Clinical Hospital Lapino, Moscow Oblast

"Clinic Mother and Child", Nizhny Novgorod

Medika-2, Novokuznetsk

Center for reproductive medicine, Novosibirsk, Novosibirsk

"Clinical Hospital Avicenna", Novosibirsk

Ceter for reproductive medicine, Omsk, Omsk

"Clinic Mother and Child Perm", Perm

"Clinic Mother and Child Rostov-on-Don", Rostov-on-Don

"Clinic Mather and Child", Ryazan

"Genesis Reproduction Centre", Saint Petersburg

"Clinic Mother and Child Saint-Petersburg", Saint Petersburg

"Clinical Hospital Mother and Child", Samara

"Clinic Mather and Child Tula", Tula

"Clinical Hospital Mother and Child", Tyumen

"Clinical Hospital Mother and Child", Ufa

"Clinic Mother and Child Vladimir", Vladimir

"Clinic Mather and Child Vladivostok", Vladivostok

"Clinic Mother and Child Volgograd", Volgograd

"Clinic Mother and Child Voronezh", Voronezh

"Clinic Mother and Child Yaroslavl", Yaroslavl

Clinical Institute of Reproductive Medicine, Yekaterinburg

All Listed Sponsors
collaborator

Institute for Preventive and Social Medicine

OTHER

lead

IVFarma LLC

INDUSTRY

NCT04854707 - An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data | Biotech Hunter | Biotech Hunter